GHK-Cu Copper Peptide 100mg – Lyophilized Powder

GHK-Cu Copper Peptide 100mg is a copper-binding peptide product supplied in lyophilized powder form for laboratory research purposes. It is packaged in a sealed 3 mL vial with a flip-top cap and is supplied as a dry powder rather than a reconstituted solution.

GHK-Cu is a peptide complex formed by glycyl-L-histidyl-L-lysine (GHK) associated with copper ions. It is widely discussed in scientific literature concerning copper-binding peptides, skin biology, and cellular research. Its properties and potential biological roles are subjects of scientific investigation; this product listing does not establish any clinical benefit or treatment effect.

At Global Peptides Lab, clear product specifications and transparent batch information are important parts of the purchasing process. The available test report for this batch includes purity, measured weight, sterility, endotoxin, and TFA results. These details help research purchasers review the reported characteristics of the supplied material before making a purchasing decision.

Key Product Features

• Product name: GHK-Cu Copper Peptide 100mg
• Peptide type: Copper-binding peptide complex
• Listed quantity: 100 mg
• Physical form: Lyophilized powder
• Reconstitution status: Not reconstituted
• Container: Sealed vial with flip-top cap
• Vial size: 3 mL
• Reported purity: 99.729%
• Endotoxin test: Pass
• Sterility test: Pass
• TFA result: Not detected
• Batch number: GHK052614100n

Please review the batch information below for the distinction between the listed product quantity and the measured weight recorded in the supplied report.

What Is GHK-Cu Copper Peptide?

GHK-Cu is a peptide-copper complex associated with the naturally occurring tripeptide GHK. A tripeptide is a short chain consisting of three amino acids. The copper component is associated with the peptide and contributes to the complex’s chemical characteristics.

Researchers have investigated GHK-Cu in areas including skin biology, extracellular matrix processes, and cellular signalling. These subjects are discussed in scientific literature, but laboratory findings should not automatically be interpreted as proof of a benefit in humans.

For research and product identification purposes, the terms GHK-Cu peptide, copper-binding peptide, and GHK-Cu peptide powder may be used to describe this material. The exact identity, composition, and quality of any particular batch should be assessed using appropriate analytical methods and supporting documentation.

Lyophilized Powder and Product Form

This copper peptide is supplied as a lyophilized powder. Lyophilization, also called freeze-drying, is a process used to remove water from a material under controlled conditions.

The supplied product has not been reconstituted into a liquid solution. Buyers should therefore distinguish this dry powder format from a ready-made liquid formulation or a cosmetic product containing copper peptides.

The vial has a nominal capacity of 3 mL and is supplied sealed with a flip-top cap. Vial capacity describes the container size; it does not independently confirm the quantity of material inside it.

No reconstitution instructions, dosage recommendations, or instructions for administration are provided with this product description. Any laboratory handling must follow the applicable safety procedures, validated research protocols, and the product’s available technical documentation.

GHK-Cu Batch Test Results

The supplied batch report provides the following results for the material identified by batch number GHK052614100n.

Test parameter	Reported result
Date tested	April 17, 2026
Batch number	GHK052614100n
Purity	99.729%
Measured weight	95.41 mg
Endotoxins (LPS)	Pass
Sterility	Pass
TFA	Not detected

Purity

The report records a purity result of 99.729%. Purity indicates the proportion of the material attributed to the target substance under the analytical method used. The exact meaning of a purity figure depends on the testing method, calibration, and reporting basis. Buyers should consult the original analytical report for the method and supporting data.

Measured Weight

Although the product is listed as 100 mg, the supplied report records a measured weight of 95.41 mg. This difference is important to disclose clearly. The measured result should not be represented as an independently confirmed 100 mg net fill. Refer to the original report and supplier documentation for clarification of the measured quantity and applicable product specifications.

Sterility and Endotoxin Testing

The supplied results mark the sterility test as “Pass” and the endotoxin test as “Pass.” These results should be understood within the scope of the testing performed. They do not, on their own, establish that a product is suitable for injection, human use, or any particular medical application.

TFA Testing

The report states that TFA was “Not detected.” This means the report did not detect trifluoroacetic acid under the method and detection limits used. It should not be interpreted as proof that every possible trace amount is absent without reviewing the test method and its detection limit.

Storage and Handling

Store lyophilized peptide materials according to the manufacturer’s documented storage requirements and the accompanying technical documentation. Protect the vial from conditions that may affect product quality, including inappropriate temperature, moisture, and unnecessary exposure to light.

Keep the vial sealed when not being examined, use appropriate laboratory handling procedures, and follow the supplier’s guidance for transport and storage. Do not assume that a specific storage temperature or shelf life applies unless it is supported by product-specific documentation.

The material should be handled only by appropriately qualified personnel in a suitable research environment. Avoid direct contact, inhalation, or accidental exposure, and consult the applicable safety documentation before handling.

Why Review Batch-Specific Documentation?

A product name alone does not establish the quality of an individual batch. Batch identification and supporting analytical information allow purchasers to connect reported test results to the material they are evaluating.

For GHK-Cu peptide powder, useful documentation may include the batch identifier, analytical method, test date, measured quantity, purity results, and applicable microbiological testing information. The scope and limitations of each test should be reviewed before drawing conclusions about quality or suitability for a particular purpose.

Global Peptides Lab aims to present product information in a clear and accessible format so that research purchasers can evaluate listed specifications alongside the relevant supporting documentation.

Frequently Asked Questions

What form does this GHK-Cu product come in?

It is supplied as lyophilized dry powder in a sealed 3 mL vial with a flip-top cap. It is not supplied as a reconstituted liquid.

What purity is reported for this batch?

The supplied report, dated April 17, 2026, records a purity of 99.729%. Review the original report for the analytical method and its limitations.

Does the report confirm a 100 mg measured fill?

The product is listed as 100 mg, but the supplied report records a measured weight of 95.41 mg. These figures are different and should not be presented as equivalent.

What are the reported sterility and endotoxin results?

Both tests are marked “Pass” in the supplied batch information. The interpretation of these results depends on the testing methods and their scope. They do not establish suitability for human use or injection.

Was TFA detected?

The supplied report states “Not detected.” The analytical method and detection limit would be needed to interpret this result more precisely.

Is this product intended for human use?

This listing is for laboratory research purposes only. It is not presented as an approved medicine, an injectable product, or a treatment for any health condition. It should not be used for self-administration or as a substitute for an approved healthcare product.

Order GHK-Cu Copper Peptide from Global Peptides Lab

GHK-Cu Copper Peptide 100mg is listed as a lyophilized research material with batch-specific results supplied for purity, measured weight, sterility, endotoxins, and TFA. Review the available documentation, listed specifications, and applicable handling requirements before purchasing.

Global Peptides Lab prioritizes clear product descriptions and accessible batch information to help research purchasers understand what is listed and what the supporting test results actually report.

Research-use notice: This material is intended for laboratory research only, not for human or veterinary use, diagnosis, treatment, or prevention of disease.